Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 6Recruiting 4Active not recruiting 3Unknown 2Terminated 1Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Colorectal Neoplasms 39Stomach Neoplasms 20Carcinoma, Hepatocellular 20Pancreatic Neoplasms 15Colonic Neoplasms 13Esophageal Neoplasms 10Liver Neoplasms 9Rectal Neoplasms 8Esophageal Squamous Cell Carcinoma 8Cholangiocarcinoma 8Breast Neoplasms 8Barrett Esophagus 8Carcinoma, Non-Small-Cell Lung 6Neoplasms 5Postoperative Complications 4Liver Cirrhosis 4Gastrointestinal Neoplasms 4Gallbladder Neoplasms 4Diabetes Mellitus 4Prostatic Neoplasms 3Ovarian Neoplasms 3Neoplasm Metastasis 3Melanoma 3Lymphatic Metastasis 3Lung Neoplasms 3Fibrosis 3Colorectal Neoplasms, Hereditary Nonpolyposis 3Anastomotic Leak 3Triple Negative Breast Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × Hereditary Breast and Ovarian Cancer Syndrome × Gastrointestinal × Clear all
NCT06914726 2025-08-05

PC-CDS

HealthPartners Institute

Phase NA Enrolling by invitation
2,488 enrolled
BreastGastrointestinalGynecologic

Colorectal Neoplasms, Hereditary Nonpolyposis, Neoplastic Syndromes, Hereditary, Ovarian Neoplasms, Hereditary Breast and Ovarian Cancer Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡